Amazon S3 on MSN
FDA approves first gene therapy for hearing loss in the US
The US Food and Drug Administration has approved the first-ever gene therapy specifically targeting genetic hearing loss—a ...
The US Food and Drug Administration has granted approval for the inaugural gene therapy aimed at addressing genetic hearing ...
10hon MSN
New 'SMArT' platform makes gene editing in hematopoietic stem cells more efficient and safer
A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a ...
One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...
Dosing of adults with early Alzheimer’s disease in clinical trial expected H2 2026 - - Comprehensive preclinical program ...
Taysha Gene Therapies is now a one-drug company, fully reliant on TSHA-102 for Rett syndrome after discontinuing its previous ...
Cardiac gene therapy was once viewed as a promising breakthrough before high-profile clinical setbacks dampened expectations. Now, advances in gene delivery, viral vectors and molecular targeting are ...
Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...
In a worldwide first, a one-and-done gene therapy has been approved to treat a form of hereditary deafness. Many of the ...
A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks ...
While gene therapy for cystic fibrosis is still in the research phase, researchers aim to correct the defective gene responsible for the disease. Current research is promising. Cystic fibrosis (CF) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results